Influenza viral hemagglutinin-targeted macrocyclic peptides as an antiviral agent
Project/Area Number |
25670224
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Virology
|
Research Institution | Tokyo Metropolitan Institute of Medical Science |
Principal Investigator |
KOHARA Michinori 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 特任研究員 (10250218)
|
Co-Investigator(Renkei-kenkyūsha) |
YASUI Fumihiko 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 主席研究員 (40399473)
MUNAKATA Tubasa 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 主席研究員 (50420237)
SAITO Makoto 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 研究員 (20433021)
MUNEKATA Keisuke 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 研究員 (30569140)
SUGA Hiroaki 東京大学, 大学院理学系研究科, 教授 (00361668)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | インフルエンザ / 特殊環状ペプチド / 感染阻害 / インフルエンザウイルス / HA蛋白質 / 抗ウイルス剤 / パントロピック / 増殖阻害 |
Outline of Final Research Achievements |
To devise smaller molecules capable of binding to the influenza viral HA and have the potential as an antiviral agent, we used an emerging technology, RaPID (Random non-standard Peptide Integrated Discovery) system. After five rounds selection of H5N1 HA-binding peptides, we found a total of 24 candidates for inhibitor HA (iHA). iHA inhibited plaque formation against different clade H5N1 viruses, A/whooper swan/Mongolia/3/05 (H5N1/Mongolia; clade 2.2) and A/whooper swan/Hokkaido/1/08 (H5N1/Hokkaido; clade 2.3). Intriguingly, iHA was effective against pandemic (H1N1) 2009 viruses more than zanamivir. These results suggest that iHA is able to inhibit replication of a wide range of H1 and H5 influenza viruses via a mechanism of its interaction with HA. Polykaryon formation mediated by various clade H5 HAs were also inhibited by iHA in a dose-dependent manner.
|
Report
(3 results)
Research Products
(13 results)
-
[Journal Article] Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus.2014
Author(s)
Yasui F, Kohara M, Kitabatake M, Nishiwaki T, Fujii H, Tateno C, Yoneda M, Morita K, Matsushima K, Koyasu S, Kai C
-
Journal Title
Virology
Volume: 454-455
Pages: 157-168
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus2013
Author(s)
Ogiwara H, Yasui F, Munekata K, Takagi-Kamiya A, Munakata T, Nomura N, Shibasaki F, Kuwahara K, Sakaguchi N, Sakoda Y, Kida H, Kohara M
-
Journal Title
Am. J. Pathol
Volume: 184
Issue: 1
Pages: 171-183
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Broad-spectrum detection of h5 subtype influenza a viruses with a new fluorescent immunochromatography system2013
Author(s)
Sakurai A, Takayama K, Nomura N, Munakata T, Yamamoto N, Tamura T, Yamada J, Hashimoto M, Kuwahara K, Sakoda Y, Suda Y, Kobayashi Y, Sakaguchi N, Kida H, Kohara M, Shibasaki F
-
Journal Title
PLoS One
Volume: 8
Issue: 11
Pages: e76753-e76753
DOI
Related Report
Peer Reviewed
-
[Journal Article] Experimental Infection of Macaques with a Wild Water Bird-Derived Highly Pathogenic Avian Influenza Virus (H5N1).2013
Author(s)
Fujiyuki, T., Yoneda, M., Yasui, F., Kuraishi, T., Hattori, S., Kwon, HJ., Munekata, K., Kiso, Y., Kida, H., Kohara, M., Kai, C.
-
Journal Title
PLoS One
Volume: 18;8(12)
Issue: 12
Pages: e83551-e83551
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] Prophylatic effect of H5N1 influenza vaccine based on vaccinia virus vector in cynomolgus monkeys2014
Author(s)
Fumihiko Yasui, Keisuke Munekata, Yasushi Itoh, Tomoko Fujiyuki, Takeshi Kuraishi, Yoshihiro Sakoda, Misako Yoneda, Hiroshi Kida, Shosaku Hattori, Chieko Kai, Kazumasa Ogasawara, Michinori Kohara
Organizer
8th Vaccine & ISV Congress
Place of Presentation
Philadelphia (USA)
Year and Date
2014-10-26 – 2014-10-28
Related Report
-
[Presentation] Prophylatic effect of H5N1 influenza vaccine based on attenuated replicative vaccinia virus that contains endogenous adjuvant component2014
Author(s)
Fumihiko Yasui, Keisuke Munekata, Yasushi Itoh, Tomoko Fujiyuki, Takeshi Kuraishi, Yoshihiro Sakoda, Misako Yoneda, Hiroshi Kida, Shosaku Hattori, Chieko Kai, Kazumasa Ogasawara, Michinori Kohara
Organizer
KeystoneSymposia
Place of Presentation
Seattle (USA)
Year and Date
2014-10-08 – 2014-10-13
Related Report
-
-